Drug intelligence / Profile preview

Mycosol-Plus

Development stage
Unknown
Lead developer
Boffin Biotech
Modality
Small Molecules
Administration
Intramuscular, Intravenous, Oral
01

Overview

Mycosol-Plus is a multivitamin combination product developed by Boffin Biotech. It is formulated as an injection or tablet containing methylcobalamin (vitamin B12), pyridoxine hydrochloride (vitamin B6), niacinamide (vitamin B3), and D-panthenol (vitamin B5). This combination is primarily used to treat or prevent vitamin deficiencies, peripheral neuropathy, diabetic neuropathy, and other neuropathic conditions. Methylcobalamin acts as a cofactor for methionine synthase, which is essential for myelin sheath formation and nerve regeneration. Pyridoxine is crucial for amino acid metabolism and neurotransmitter synthesis. Niacinamide serves as a precursor to NAD+ and NADP+, supporting cellular energy production, while D-panthenol is a precursor to coenzyme A, which is vital for fatty acid synthesis and energy metabolism.

Brand names
Mycosol PlusMycosol-Plus
Other names
methylcobalamin + pyridoxine + niacinamide + D-panthenolmethylcobalamin + pyridoxine + niacinamide + dexpanthenolmethylcobalamin + pyridoxine hydrochloride + niacinamide + dexpanthenol
02

Targets

MTR (Methionine synthase)PDXK (Pyridoxal kinase)

Beyond the preview

Go deeper on Mycosol-Plus.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mycosol-Plus.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call